Acadian Asset Management LLC Magenta Therapeutics, Inc. Transaction History

Acadian Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	SELL	$0.62 - $0.79 $97,044 - $123,653	-156,523 Reduced 25.48%	457,690 $346,000
Q1 2023 May 11, 2023	BUY	$0.41 - $0.86 $202,300 - $424,336	493,415 Added 408.46%	614,213 $486,000
Q4 2022 Feb 14, 2023	BUY	$0.36 - $1.59 $9,272 - $40,952	25,756 Added 27.1%	120,798 $46,000
Q3 2022 Nov 14, 2022	BUY	$1.26 - $2.09 $26,588 - $44,103	21,102 Added 28.54%	95,042 $132,000
Q2 2022 Aug 09, 2022	BUY	$0.97 - $3.08 $53,027 - $168,377	54,668 Added 283.67%	73,940 $89,000
Q1 2022 May 12, 2022	BUY	$2.55 - $5.23 $32,219 - $66,081	12,635 Added 190.37%	19,272 $55,000
Q4 2021 Feb 10, 2022	BUY	$4.43 - $8.33 $29,401 - $55,286	6,637 New	6,637 $29,000

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.